STEALTH BIOTHERAPEUTICS CORP's ticker is MITO and the CUSIP is 85789A105. A total of 13 filers reported holding STEALTH BIOTHERAPEUTICS CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,000 | +16.7% | 43,790 | -9.5% | 0.00% | – |
| Q2 2022 | $12,000 | -64.7% | 48,397 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $34,000 | -15.0% | 48,397 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $40,000 | -39.4% | 48,397 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $66,000 | -26.7% | 48,397 | -16.3% | 0.00% | -33.3% |
| Q2 2021 | $90,000 | -38.8% | 57,850 | -38.1% | 0.00% | -50.0% |
| Q1 2021 | $147,000 | – | 93,411 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 488,014 | $761,000 | 0.06% |
| PVG ASSET MANAGEMENT CORP | 11,988 | $18,701,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 57,850 | $90,000 | 0.00% |
| BROWN BROTHERS HARRIMAN & CO | 174,999 | $273,000 | 0.00% |
| Sargent Bickham Lagudis LLC | 14,714 | $23,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 88,426 | $138,000 | 0.00% |
| MORGAN STANLEY | 6,000 | $9,000 | 0.00% |
| HRT FINANCIAL LP | 17,467 | $27,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 22,700 | $35,000 | 0.00% |
| Renaissance Technologies | 81,877 | $128,000 | 0.00% |